BIO’s new CEO, John Crowley, is a longtime board member — and the inspiration fo...
CVS, the nation’s largest drugstore chain, will move away from the complex formu...
Eight months into his tenure, Johnson & Johnson’s R&D chief is putting a big emp...
Despite financial pressure to focus on adults, "we will go kids-first,” vows the...
Pfizer, Moderna, GSK, and Sanofi are all working on mRNA flu shots. But how well...
Anti-abortion laws intended to protect the unborn threaten lifesaving fetal surg...
President Biden’s new plan to curb drug shortages won't help with cancer drug sh...
The FDA will need dozens more reviewers if its so-called Operation Warp Speed fo...
In the wake of the Covid-19 pandemic, the FDA inspected far fewer domestic and f...
The Senate health care committee will soon consider a sweeping bill that, if pas...
The Supreme Court on Monday wrestled with a nationwide settlement with OxyContin...
Understand how science, health policy, and medicine shape the world everyday. Si...
The pharmaceutical giant Pfizer plans to exit the Biotechnology Innovation Organ...
Drug pricing experts said CVS’ new program appears designed to pad CVS’ own bott...
Drug shortage fixes have eluded Congress, and a Senate panel heard about Medicar...
The GLP-1 market is growing quickly. But an analyst noted that with other herald...
